
    
      This is a randomized, double blind, multicenter, parallel group, outpatient study evaluating
      the efficacy and safety of dasotraline in adults with ADHD using 2 doses of dasotraline (4
      mg/day or 6 mg/day) versus placebo over an 8 week treatment period (8 weeks of active
      treatment followed by a 2-week withdrawal phase).
    
  